ARTICLE
|
doi:10.20944/preprints202310.0836.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
hepatocellular carcinoma; unresectable; atezolizumab plus bevacizumab; lenvatinib
Online: 12 October 2023 (15:36:58 CEST)
ARTICLE
|
doi:10.20944/preprints202407.0186.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
atezolizumab; bevacizumab; hepatocellular carcinoma; EGD; varices; GI bleeding
Online: 2 July 2024 (06:01:14 CEST)
ARTICLE
|
doi:10.20944/preprints202403.0593.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
large cell neuroendocrine carcinoma; LCNEC; immunotherapy; atezolizumab; miR375
Online: 11 March 2024 (17:49:38 CET)
ARTICLE
|
doi:10.20944/preprints202306.1767.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
hepatocellular carcinoma; tumor marker; atezolizumab plus bevacizumab; prognosis; predictive model
Online: 26 June 2023 (09:42:06 CEST)
ARTICLE
|
doi:10.20944/preprints202307.1474.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
Hepatocellular carcinoma; Atezolizumab–bevacizumab; Hepatic artery infusion chemotherapy; Overall survival; Progression-free survival
Online: 21 July 2023 (14:00:43 CEST)
ARTICLE
|
doi:10.20944/preprints202310.1682.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
Atezolizumab; bevacizumab; non-alcoholic fatty liver disease; non-alcoholic steato hepatitis; albumin-bilirubin (ALBI) score
Online: 26 October 2023 (09:01:45 CEST)
ARTICLE
|
doi:10.20944/preprints202111.0447.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Immunotherapy; immune-checkpoint inhibitor; response prediction; men and women; pembrolizumab; nivolumab; atezolizumab; ECOG; CRP; chemo-immunotherapy
Online: 24 November 2021 (09:02:46 CET)
ARTICLE
|
doi:10.20944/preprints202105.0546.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
triple negative breast cancer; Pembrolizumab; Atezolizumab; chemotherapy; anti-PD-L1; biomarkers; targeted therapies; development of novel drugs
Online: 24 May 2021 (09:23:50 CEST)
ARTICLE
|
doi:10.20944/preprints201808.0307.v3
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Immune Checkpoint Inhibitors; anti-PD-1/PDL-1; anti-CTLA-4; gender; sex; Nivolumab; Pembrolizumab; Atezolizumab; Ipilimumab; Durvalumab
Online: 15 November 2018 (07:02:24 CET)
ARTICLE
|
doi:10.20944/preprints202103.0777.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Exosomal PD-L1 mRNA; extracellular vesicles; Triple Negative Breast Cancer; Immunotherapy; PD-L1 axis; Atezolizumab – nab-paclitaxel; Predictive biomarkers; Liquid biopsy
Online: 31 March 2021 (15:27:45 CEST)